Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations Prevention

NCT01282359 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2015-09-16

No results posted yet for this study

Summary

The asthma clinical practice guidelines categorize with the highest evidence level the effectiveness of educational programs. However, health care professionals not regularly applied it. This may contribute to inadequate control of the disease. Consequently, their designs and implementation strategies should be reviewed.

Hypothesis. An asthma educational program based on a limited intervention, managed by professionals with minimal training in education, could provide a significant decrease in the morbidity of the disease.

Objective. Determine the effectiveness, in terms of prevention of exacerbations (future risk) and improved asthma control (current control) of an educational program based on a reduced or minimal intervention.

Conditions

Interventions

OTHER

Clinical practice group

Clinical practice group will not receive any specific education

OTHER

"Gold Standard" educational group

"Gold Standard" educational group will receive a formal program of structured and individualized education

OTHER

Intervention group

Intervention group will take the limited educational asthma program which have three parts: basic information, establishment and revision of a small Action Plan (MiniPlan) and training and review of the inhalation skill of the prescribed device. Educators involved will attend a short workshop (6 h), where they will be trained in the program.

Sponsors & Collaborators

  • Sociedad Española de Neumología y Cirugía Torácica

    collaborator OTHER
  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Antolin Lopez, MD · Hospital Universitario Puerta Hierro Madrid (Spain)

  • Meritxell Peiro · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

  • José M Ignacio, MD · Hospital Serrania de Ronda. Málaga (Spain).

  • José A Quintano, MD · Centro de Salud Lucena I. Lucena. Córdoba (Spain).

  • Santiago Bardagí, MD · Hospital de Mataró. Barcelona (Spain)

  • Vicente Plaza, MD · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-04-30
Completion
2013-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282359 on ClinicalTrials.gov